3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Classical hematology
1
Conditions
Breast Neoplasms
11
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Ovarian Neoplasms
5
Endometrial Neoplasms
4
Colorectal Neoplasms, Hereditary Nonpolyposis
4
Brain Neoplasms
3
Urogenital Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms, Unknown Primary
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Head and Neck Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8
1
Wilms Tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Pyloric Stenosis, Hypertrophic
1
Primary Ovarian Insufficiency
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Pancreatic Ductal Adenocarcinoma
1
Neurofibromatosis 1
1
Neoplastic Syndromes, Hereditary
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lipodystrophy, Familial Partial
1
Leukemia, Myeloid, Acute
1
Interventions
Vincristine
16
Cyclophosphamide
16
Filgrastim
13
Etoposide
12
Doxorubicin
12
Radiotherapy
11
Carboplatin
10
X-Rays
9
Dactinomycin
9
Specimen Handling
8
Phantoms, Imaging
8
Magnetic Resonance Spectroscopy
8
Granulocyte Colony-Stimulating Factor
8
Temozolomide
6
Melphalan
6
Ifosfamide
6
Topotecan
5
Peripheral Blood Stem Cell Transplantation
5
Nuclear Medicine Department, Hospital
5
Irinotecan
5
Busulfan
5
Biopsy
5
sargramostim
4
Stem Cell Transplantation
4
Thiotepa
3
Radiation
3
Nivolumab
3
Mesna
3
Itraconazole
3
Cisplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Wilms Tumor
×
Genetic Testing
×
Clear all
NCT04168788
2019-11-19
MVO
University Hospital, Angers
Phase NA
Unknown
150 enrolled